(Q42418734)

30 October 2017

HPV vaccination in women aged 24-45 years. (English)

1 reference

30 October 2017

5

Mark Schiffman

1 reference

30 October 2017

6

Sholom Wacholder

1 reference

30 October 2017

4

Hormuzd A Katki

1 reference

30 October 2017

3

Allan Hildesheim

1 reference

30 October 2017

1

Diane Solomon

1 reference

30 October 2017

Phil Castle

2

1 reference

PMC publication ID

2946099

30 October 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

30 October 2017

1 reference

30 October 2017

374

1 reference

30 October 2017

9697

1 reference

30 October 2017

1239; author reply 1239-40

1 reference

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946099

PubMed Central

reference URL

Age-appropriate use of human papillomavirus vaccines in the U.S.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946099

PubMed Central

reference URL

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

28 May 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961782-7

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(09)61782-7

1 reference

30 October 2017

1 reference

PMC publication ID

2946099

30 October 2017

PubMed publication ID

19819386

1 reference

PMC publication ID

2946099